repaglinide, a new oral hypoglycemic for type 2 diabetes
July 1999
Novo Nordisk is now marketing repaglinide, a new oral hypoglycemic for type 2 diabetes.
It's called GlucoNorm in Canada...and Prandin in the U.S.
This new drug is approved for use by itself...or in combination with metformin (Glucophage).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote